Anti-Amyloid Precursor Protein antibody [Y188] (Ab32136)

A4, AD1, APP, Amyloid-beta precursor protein, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II

反应种属:Human, Mouse, Rat
抗原名称:APP
应用:WB, IHC, IF/ICC, IP

详细信息

免疫原The exact immunogen used to generate this antibody is proprietary information.
宿主/亚型Rabbit / IgG
抗体类型Monoclonal
产品形式Liquid
纯化方式Affinity purification Protein A
储存缓冲液pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
储存条件运输条件: Conditional Ambient 推荐的短期储存条件: +4°C 推荐的长期储存条件: -20°C 储存信息: Avoid freeze / thaw cycle
无载体蛋白No

特异性

The antibody detects the C-terminal fragment of APP (APP-CTF). The immunogen used for this product is within Human Amyloid Precursor Protein aa 750 to the C-terminus and therefore may detect gamma secretase fragments 50, 57 and 59 in addition to fragments C31, C80, C83 and C99. Cross-reactivity with these fragments has not been confirmed experimentally.

背景信息

Anti-Amyloid Precursor Protein antibody [Y188] (ab32136) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ICC/IF, IHC-P, IP and WB. Anti-Amyloid Precursor Protein antibody [Y188] (ab32136) was first used in a scientific publication in 1984 and has been cited over 242 times in peer reviewed journals. It's performance in Western Blot in human, mouse and rat samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-Amyloid Precursor Protein antibody [Y188] (ab32136) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-Amyloid Precursor Protein antibody [Y188] (ab32136) has been confirmed by Western Blot testing in Amyloid Precursor Protein knockout HEK-293T cells. Anti-Amyloid Precursor Protein antibody [Y188] (ab32136) has 8 independent reviews from customers. Anti-Amyloid Precursor Protein antibody [Y188] (ab32136) specifically detects Amyloid Precursor Protein (UniProt ID: P05067; Molecular weight: 86kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Conjugation-ready, carrier free format available for antibody clone Y188 - ab220793. Antibody clone Y188 is also available pre-conjugated to a variety of labels for your convenience - HRP, PE, Alexa Fluor ® 488, Alexa Fluor ® 647, Alexa Fluor ® 594, Alexa Fluor ® 568, Alexa Fluor ® 555, Alexa Fluor ® 750 ( ab199550, ab208744, ab310994, ab311119, ab311748, ab313028, ab313229, ab321579 ). APP (Amyloid Precursor Protein) is a critical protein in neuro research, particularly for its role in the pathogenesis of Alzheimer's disease (AD). It is cleaved to produce amyloid-beta (beta-Amyloid, A-beta) peptides, which aggregate to form plaques, a hallmark of AD pathology. Researchers use APP to study the mechanisms of amyloid-beta production, aggregation and its effects on neuronal function and survival, making it essential for understanding and developing treatments for AD. Its expression and processing are key factors in the progression of neurodegenerative conditions. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.

文献引用 (279)

Neuronal subtype governs amyloid structure, cellular response, and cognitive outcome in genetically targeted APP mouse models.

在基因靶向 APP 小鼠模型中,神经元亚型决定淀粉样蛋白结构、细胞反应和认知结果。

Perez Gabriella A, Lai Zoe, Edwards Iii George A, Dundee Jacob M, Leahy Shannon N, Qi Chuangye, Qi Yanyan, Park Ye-Jin, Lu Tzu-Chiao, Uddin M Danish, Zhao Rong, Zheng Hui, Li Hongjie, Jankowsky Joanna L

Predifferentiation Neurotoxicity of GenX Exposure on hiPSC-Derived Cortical Neurons.

GenX暴露对hiPSC衍生皮层神经元的分化前神经毒性。

Wu Shichen, Xie Junkai, Zhao Xihui, Zhao Han, Sánchez Oscar F, Yu Serena, Rochet Jean-Christophe, Freeman Jennifer L, Yuan Chongli

Region-specific brain structural modulation and amyloid-β pathology associated with dietary biotin: insights into dementia neuropathology.

区域特异性脑结构调节和与膳食生物素相关的淀粉样蛋白β病理:对痴呆神经病理学的见解。

Zhang Junhan, Yang Celi, Tan Yuefeng, Na Muzi, Shakya Evaniya, Zhang Da, Shi Xiaojin, Na Xiaona, Li Zhihui, Ji John S, Yang Yucheng, Zhao Ai

5-Hydroxymethylcytosine profiles in circulating cell-free DNA serve as potential biomarkers for diagnosis and classification of adenomyosis.

循环游离DNA中的5-羟甲基胞嘧啶谱可作为诊断和分类子宫腺肌症的潜在生物标志物。

Zhang Lei, Han Xiaotong, Gao Xinran, Chen Hangyu, Shang Chunliang, Chen Long, Lin Jian, Guo Hongyan

De-2-hydroxyisobutyrylation of clusterin modulates neuropathology and memory deficits in an Alzheimer's disease mouse model.

簇蛋白的去-2-羟基异丁酰化作用调节阿尔茨海默病小鼠模型中的神经病理学和记忆缺陷。

Peng Xiaoping, Ouyang Chaoyue, Ma Fubin, Liu Yu, Luo Lv, Xing Jiawei, Feng Sifan, Li Li, Zhang Jiahao, Wang Jiaying, Cheng Helei, Zhang Tianying, Chen Feng, Wang Yan, Cui Lili

Central nervous system-penetrant anti-C1q therapy reduces neuroinflammation and preserves neurological function in a model of progressive multiple sclerosis.

中枢神经系统穿透性抗 C1q 疗法可减轻进行性多发性硬化症模型中的神经炎症并保护神经功能。

Linzey Michael, Pike Steven C, Bouzid Nour-Maria, Scholand Aine, Cruz Cinthia Gonzalez, Philips Andrew, DeCristofano Laura, Tran Hiep, Gilli Francesca

Synaptic Vesicle Glycoprotein 2A Suppresses Amyloidogenesis Beyond Its Synaptic Role: A Novel Mechanism Disrupting BACE1 Binding and Altering APP Localization.

突触囊泡糖蛋白 2A 抑制淀粉样蛋白形成,超越其突触作用:一种破坏 BACE1 结合和改变 APP 定位的新机制。

Wang Xiaoling, Zhang Qian, Zhang Xiaomin, Liu Jing, Zhang Jingjing, Liu Congcong, Cui Yuting, Song Qiao, Hou Yuli, Wang Yaqi, Cao Min, Wang Peichang

Long noncoding RNA GAS5 acts as a competitive endogenous RNA to regulate GSK-3β and PTEN expression by sponging miR-23b-3p in Alzheimer's disease.

长链非编码 RNA GAS5 作为一种竞争性内源 RNA,通过吸附 miR-23b-3p 来调节阿尔茨海默病中的 GSK-3β 和 PTEN 表达

Zeng Li, Zhao Kaiyue, Liu Jianghong, Liu Mimin, Cai Zhongdi, Sun Ting, Li Zhuorong, Liu Rui

Nobiletin Ameliorates Alzheimer's Disease Pathology by Reducing Oxidative Stress and Neuroinflammation Through the AMPK/SIRT1/PGC-1α and PI3K/Akt-CREB-BDNF Pathways in 5XFAD Mice.

诺比列汀通过 AMPK/SIRT1/PGC-1α 和 PI3K/Akt-CREB-BDNF 通路减少氧化应激和神经炎症,从而改善 5XFAD 小鼠的阿尔茨海默病病理。

Baek Hana, Park Miey, Lee Hae-Jeung

RhoGEF12 regulates endosomal SORL1-retromer and its inhibition is therapeutic in human neuronal models of Alzheimer's disease.

RhoGEF12 调节内体 SORL1 逆转录酶,抑制 RhoGEF12 在阿尔茨海默病的人类神经元模型中具有治疗作用。

Qureshi Yasir H, Williams Charles A, Hajdu Istvan, Kannan Suvarnambiga, Govindarajan Ananya, Végh Barbara, Petsko Gregory A, Young Jessica E, Závodszky Péter, Small Scott A
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 28